Search results
ASLAN expands research on atopic dermatitis treatment By Investing.com
Investing.com· 3 days agoASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage biopharmaceutical company, has announced a new...
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 6 days agoA decision on approval is expected in the fourth quarter of 2024.
How to Spot and Take Care of Your Newborn’s Rash
Verywell Health via Yahoo News· 6 days agoIf it persists, your provider may prescribe a cream or shampoo. Eczema Eczema (atopic dermatitis) makes the skin itchy, dry, and scaly, leading to red...
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 5 days agoOpzelura cream 1.5% is approved for the topical treatment of non-segmental vitiligo in adult and...
Itchy Nipples? Here Are 9 Potential Causes
PopSugar· 6 days agoA quick google search for "itchy nipples" or "why does my nipple itch" can quickly send you down an anxiety-inducing medical rabbit hole. Results like...
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After...
NBC 10 - FOX 14 Monroe· 3 days agoNektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based financial markets. Howard Robin, President ...
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoAn increase in profits from Dupixent and further uptake of Eylea HD are likely to have aided...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 2 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
Regeneron’s stock rallies as pipeline prospects outweigh earnings miss
Market Watch· 3 days agoThe revenue shortfall was partly due to a decline in sales of the company’s blockbuster eye drug...
Report offers several reasons to take part in a clinical trial
Local 12 Cincinnati· 6 days agoA recent report from the National Institutes of Health shows lots of reasons to participate in a...